Overview of Tesamorelin

Tesamorelin is a synthetic GHRH analogue featuring a trans-3-hexenoic acid group attached to the N-terminus. This modification dramatically increases resistance to enzymatic degradation compared to native GHRH and Sermorelin, producing more sustained GHRH receptor activation. Tesamorelin has been extensively studied in clinical research on visceral adiposity and metabolic parameters.

Each vial available from SteroidsCanada.ca contains 5mg of lyophilized Tesamorelin, manufactured to rigorous pharmaceutical-grade standards and independently verified for purity exceeding 99% via HPLC analysis. This makes it an ideal choice for qualified researchers and laboratory professionals seeking dependable, high-quality peptides for ghrh analogue research applications.

Mechanism of Action

Tesamorelin activates GHRH receptors on pituitary somatotrophs, stimulating robust endogenous GH release. Its modified structure provides enhanced stability against DPP-IV degradation and extended receptor engagement compared to unmodified GHRH analogues. Published research has particularly focused on its selective effects on visceral adipose tissue and lipid profile modulation.

Key Research Applications

Product Specifications

Reconstitution Guidelines

Tesamorelin is supplied as a lyophilized (freeze-dried) powder that must be reconstituted with sterile bacteriostatic water (0.9% benzyl alcohol) before use in research applications. The recommended reconstitution volume for this vial is 2mL of bacteriostatic water, which yields a concentration suitable for precise research dosing.

Reconstitution Math — Quick Reference

If you add 2mL of bacteriostatic water to this 5mg vial:

On a standard 100 IU insulin syringe, here’s what each measurement equals for research reference:

Reconstitution Best Practices

• Use sterile bacteriostatic water (0.9% benzyl alcohol preservative)
• Add diluent slowly along the vial wall — never directly onto the peptide cake
• Gently swirl to dissolve — never shake the vial vigorously
• Allow the peptide to fully dissolve before drawing any dose
• Store reconstituted vials at 2–8°C (refrigerator)
• Use reconstituted peptide within 28–60 days depending on specific research requirements
• Always use sterile technique when drawing from the reconstituted vial

Research Protocol Guidelines

Research protocols commonly use 1-2mg daily, typically at bedtime for enhanced nocturnal GH pulse amplification.

Typical Research Timeline

• Week 1-4: Initial GHRH receptor adaptation
• Week 5-12: Peak visceral adipose research effects
• Week 13-20: Extended research protocol phase
• Week 21-26: Long-duration study plateau

Individual research results vary based on protocol design, specific research objectives, and research model characteristics. The above timeline represents commonly observed patterns in published research literature.

Research Stacking Protocols

In research applications, Tesamorelin is often studied in combination with complementary research peptides to investigate pathway interactions. Common research combinations include:

• Tesamorelin + Ipamorelin: Enhanced GHRH+GHRP research
• Tesamorelin + BPC-157: GH + tissue research
• Tesamorelin + AOD 9604: Advanced metabolic research

Any research stacking protocol should be designed based on specific investigative objectives and informed by current scientific literature.

Why Choose SteroidsCanada.ca?

• ✅ Pharmaceutical-grade Tesamorelin — lab tested for purity and potency
• ✅ Discreet shipping across Canada — plain outer packaging always
• ✅ Proper cold-chain handling to preserve peptide integrity
• ✅ Same-day dispatch on orders placed before 2PM EST
• ✅ COA available on request for every batch and SKU
• ✅ Secure payment — Interac E-Transfer and cryptocurrency
• ✅ Free shipping on all orders over $600 CAD
• ✅ Competitive Canadian pricing with no hidden fees
• ✅ Responsive customer service and reliable restocking